Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: Life Sciences
STAT+: Pharmalittle: Novo Nordisk sees “significantly” more Wegovy in the U.S. next year; U.S. pharma layoffs skyrocket
Top of the morning to you. And a fine one it is. Lots of sunshine…
Opinion: Do celebrity vaccine endorsements like Travis Kelce’s actually change behavior?
Once the domain of aging TV stars, hawking health products from vitamins to diabetes supplies…
Treating Rural America: The telehealth solution
There is a persistent shortage of primary care doctors in the rural United States. Specialists,…
With a new center, All of Us tackles health data silos to power precision medicine
Over the past five years, two unique federal efforts have collected the health records of…
Opinion: Let’s leverage graduate medical education to increase Medicaid re-enrollment
Lately, we’ve seen two distinct lines at our hospitals. We would all be healthier if…
Bible of Alternative Medicine Reviews (Ralph La Guardia) Is It Legit … – Kent Reporter
Bible of Alternative Medicine Reviews (Ralph La Guardia) Is It Legit … Kent Reporter Read Original…
Las Vegas Integrative Medicine Expands To Help More Local Veterans and Families – KLAS – 8 News Now
Las Vegas Integrative Medicine Expands To Help More Local Veterans and Families KLAS – 8 News…
New antibiotic targets gonorrhea as well as last existing treatment, study shows
An important Phase 3 trial has shown that a new drug that targets gonorrhea works…
STAT+: After Sarepta trial failure, families and doctors brace for another debate on Duchenne therapy
To hear Sarepta CEO Doug Ingram tell it, the results Monday afternoon from a large…
STAT+: New insights into how tumor cells hijack brain plasticity to drive cancer
The idea that cancer can hijack brain plasticity — subverting supple connections in the healthy…
STAT+: Nostrum Laboratories and its CEO — who once defended Shkreli price hikes — to pay up to $50 million over Medicaid rebates
A pharmaceutical company and its chief executive — who once defended Martin Shkreli for raising…
American Cancer Society expands lung cancer screening guidelines for cigarette smokers
Most lung cancer screening guidelines hinge on how much people smoked tobacco and when they…
Infant mortality in the U.S. rose last year for the first time in two decades, says CDC
The U.S. infant mortality rate rose 3% last year — the largest increase in two…
STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
.jpg)
Gene editing has had a big week in the spotlight. Here’s what’s going on
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Life science investors close nearly $6 billion in new funds
Biotech and life sciences investors continue to draw in new funds even as the biotech…
The scientist studying how fugitive fetal cells may affect maternal health
Chimeras — fantastical creatures composed of different animal parts — have appeared across cultures representing…
Opinion: Listen: Sniffing out the power, and limits, of the placebo effect
Have you ever taken phenylephrine for a stuffed-up nose and then felt better? If so,…
STAT+: Venture capitalists want to own hospitals. Can they do better than private equity?
General Catalyst’s plan to take over a hospital in the coming months could be the…
Opinion: How the government can help lower the price — not just the cost — of cutting-edge gene therapies
At the bustling Chicago O’Hare airport, my luggage and I collided with an elderly couple….
Why Notre Dame of Maryland plans to acquire a Laurel alternative … – The Business Journals
Why Notre Dame of Maryland plans to acquire a Laurel alternative … The Business Journals Read…
Second recipient of genetically modified pig heart dies, six weeks after surgery
Nearly six weeks after his surgery, the world’s second recipient of a genetically modified pig…
STAT+: Medicare is urged to consider Amgen patent maneuvers when negotiating the price for a drug
As Medicare prepares to negotiate prices for its first batch of medicines, an advocacy group…
STAT+: DeepMind touts AlphaFold’s new skills as protein-folding AI models face off
On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next…
STAT+: White House AI order calls for crackdown on abuses, harms in health care
President Biden’s executive order on artificial intelligence amounts to a giant course correction in health…
La ‘paradoja hispana’ intriga a una nueva generación de investigadores decididos a resolverla
Read in English | Leer en inglés. Durante 40 años, los investigadores han intentado sin…
Sarepta’s disappointing data put the FDA in a difficult spot
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Sarepta Duchenne therapy misses primary endpoint; FDA holds panel for first CRISPR treatment for sickle cell
Rise and shine, everyone, another busy day is on the way. We can tell by…
New CDC campaign asks health care leaders to take responsibility for reducing burnout
Often, workplace conversations about burnout put the onus on the individual to take care of…
STAT+: Eli Lilly to pay $200 million for Beam’s share of drugs from gene-editing firm Verve
Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics…
How skeptical should you be of an after-the-fact subgroup analysis in a failed clinical trial?
This article was adapted from STAT’s latest report, “Subgroup analysis: how to evaluate post hoc…
Opinion: I lost my son to OxyContin. ‘The Fall of the House of Usher’ is my Sackler revenge fantasy
Editor’s note: This essay contains spoilers for the Netflix show “The Fall of the House…
Opinion: Health care providers need help to treat patients during extreme heat events
The world’s hottest summer on record is now bleeding into the fall. Instead of enjoying…
STAT+: Tracking the FDA advisory panel on the first CRISPR-based treatment for sickle cell disease
The Food and Drug Administration is convening a meeting of outside experts on Tuesday to…
In Gaza, the Glia Project 3D prints tourniquets and stethoscopes
Tarek Loubani looked around at his fellow doctors at Al Shifa Hospital in Gaza City…
Alternative health care business opens in New Albany – Evening News and Tribune
Alternative health care business opens in New Albany Evening News and Tribune Read Original Article: Alternative…
On the eve of Halloween, the FDA weighs whether medicine should ever taste like candy
WASHINGTON – M&Ms, Reese’s, gummy bears, and even cotton candy made an appearance at the…
STAT+: Sarepta’s Duchenne gene therapy fails to meet primary endpoint in pivotal trial
Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to…
In new order on AI, Biden is scrambling to catch up to emerging risks in health care
President Joe Biden ordered the nation’s leading health agencies on Monday to develop a plan…
STAT+: Cassava pulled back the curtain on its Alzheimer’s study — and revealed insurmountable problems
Cassava Sciences has long claimed its experimental drug, called simufilam, slows the cognitive decline of…
Your Monday morning biotech news roundup
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: FDA flags safety concerns with CRISPR-based sickle cell treatment; FDA warns about eye drop infection risk
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Extreme heat could lead to 233% increase in U.S. excess cardiovascular deaths, study says
When the human body is exposed to extreme heat, it tries to fight back. To…
STAT+: Virtual care options flood the market as retailers take telehealth mainstream
When patients go shopping today, they might find themselves checking out with more than the…
STAT+: What to know about Sarepta’s upcoming data on its Duchenne gene therapy
In the next few weeks, Sarepta Therapeutics will release new data that could change the…
STAT+: Colorado pioneered legal marijuana without sparking ‘reefer madness,’ but challenges lie ahead
DENVER — On Jan. 1, it will be 10 years since customers lined up in…
STAT+: An exit interview with Bristol Myers Squibb CEO Giovanni Caforio
It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb. On Wednesday, CEO…
STAT+: For hospitals after No Surprises Act, physician subsidies are ‘the new contract labor’
Physician staffing firms, flailing in the wake of a federal law banning surprise bills, are…
Opinion: Liquid biopsy for cancer recurrence creates a new kind of patient-in-waiting
My husband’s cancer came back this summer after not being evident for almost two years….